<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="4-part\PMC7243378\results\search\disease\results.xml">
  <result pre="Abstract Abstract Background Understanding local epidemiology and etiologies of community-acquired" exact="pneumonia" post="in hospitalized patients is crucial for determining the appropriateness"/>
  <result pre="the etiologies, severity, and outcomes in adults hospitalized for community-acquired" exact="pneumonia" post="and to study the impact of empirical antibiotic therapy"/>
  <result pre="a prospective observational cohort study involving adults hospitalized for community-acquired" exact="pneumonia" post="in Hong Kong. Sputum, nasopharyngeal aspirate, blood, and urine"/>
  <result pre="had bacterial, and 9% had polymicrobial pneumonia. Streptococcus pneumoniae (12%)," exact="influenza" post="virus (12%), and Mycoplasma pneumoniae (1.2%) were the most"/>
  <result pre="with doxycycline, which was less evaluated in other cohorts. community-acquired" exact="pneumonia" post="length of stay mortality treatment guidelines Funding Health and"/>
  <result pre="cause of death worldwide [1]. The annual incidence of community-acquired" exact="pneumonia" post="(CAP) in the United States was 25 cases per"/>
  <result pre="symptoms with or without fever, and (3) evidence consistent with" exact="pneumonia" post="on chest radiograph. Patients were excluded if they had"/>
  <result pre="excluded if they had one of the following: (1) hospital-acquired" exact="pneumonia" post="(occurring ≥48 hours after admission; (2) recent hospitalization in"/>
  <result pre="conditions predisposing to noncommunity-acquired pathogens (including tracheostomy, percutaneous gastrostomy tube," exact="cancer" post="with neutropenia, solid or hematopoietic stem cell transplant within"/>
  <result pre="criteria were reported to be associated with drug-resistant pathogens for" exact="pneumonia" post="[2, 4]. Informed consent was obtained from each patient"/>
  <result pre="day of admission and use of corticosteroid (for exacerbation of" exact="chronic obstructive pulmonary disease" post="or asthma) were documented. Clinical outcomes, including the 30-day,"/>
  <result pre="included in the analysis. Acid-fast smear with culture of Mycobacterium" exact="tuberculosis" post="was performed if pulmonary tuberculosis was suspected. In-house multiplex"/>
  <result pre="Acid-fast smear with culture of Mycobacterium tuberculosis was performed if" exact="pulmonary tuberculosis" post="was suspected. In-house multiplex real-time polymerase chain reactions (PCRs)"/>
  <result pre="smear with culture of Mycobacterium tuberculosis was performed if pulmonary" exact="tuberculosis" post="was suspected. In-house multiplex real-time polymerase chain reactions (PCRs)"/>
  <result pre="urinary antigen tests (Alere BinaxNOW; Abbott, Chicago, IL). Definitions Bacterial" exact="pneumonia" post="was defined as isolation of clinically significant pathogen from"/>
  <result pre="antigen tests, or positive Mycoplasma or Chlamydophila PCR tests. Viral" exact="pneumonia" post="was defined as positive respiratory viruses detected via PCR."/>
  <result pre="was defined as positive respiratory viruses detected via PCR. Polymicrobial" exact="pneumonia" post="was defined as the presence of 2 or more"/>
  <result pre="of 2 or more bacterial, viral, and/or mycobacterial pathogens. Severe" exact="pneumonia" post="was defined as CURB-65 score ≥3 [6], and/or requirement"/>
  <result pre="recommended. Empirical fluoroquinolone is only recommended for patients with documented" exact="allergy" post="to beta-lactam antibiotics. Statistical Analysis Continuous variables were presented"/>
  <result pre="patients (Table 1, Supplementary Figure 1). Fifty-two patients (20%) had" exact="viral pneumonia" post="(most commonly influenza viruses [12%] and rhinovirus [7%]), 38"/>
  <result pre="(Table 1, Supplementary Figure 1). Fifty-two patients (20%) had viral" exact="pneumonia" post="(most commonly influenza viruses [12%] and rhinovirus [7%]), 38"/>
  <result pre="Figure 1). Fifty-two patients (20%) had viral pneumonia (most commonly" exact="influenza" post="viruses [12%] and rhinovirus [7%]), 38 (15%) had bacterial"/>
  <result pre="commonly influenza viruses [12%] and rhinovirus [7%]), 38 (15%) had" exact="bacterial pneumonia" post="(S pneumoniae [12%], Hemophilus influenzae [7%], and M pneumoniae"/>
  <result pre="influenza viruses [12%] and rhinovirus [7%]), 38 (15%) had bacterial" exact="pneumonia" post="(S pneumoniae [12%], Hemophilus influenzae [7%], and M pneumoniae"/>
  <result pre="and Legionella 1). Bacterial pathogens in 93% of patients with" exact="bacterial pneumonia" post="(excluding atypical pathogens) were susceptible to amoxicillin-clavulanate. Table 1."/>
  <result pre="Legionella 1). Bacterial pathogens in 93% of patients with bacterial" exact="pneumonia" post="(excluding atypical pathogens) were susceptible to amoxicillin-clavulanate. Table 1."/>
  <result pre="3 (1.2%) 1 (3.3%) 0 (0%) 2 (1.8%) .229  Mycobacterium" exact="tuberculosis" post="5 (1.9%) 1 (3.3%) 4 (3.5%) 0 (0%) .137"/>
  <result pre="had rhinovirus and S pneumoniae or Hemophilus influenzae, 7 had" exact="influenza" post="and S pneumoniae or H influenzae or Legionella, 3"/>
  <result pre="2 had respiratory syncytial virus and S pneumoniae, 1 had" exact="influenza" post="and mycobacterial, 1 had S pneumoniae and mycobacterial, and"/>
  <result pre="Figure 1. Screening and enrollment of patients hospitalized with community-acquired" exact="pneumonia" post="(CAP). The aetiologic type of pneumonia varied by age"/>
  <result pre="patients hospitalized with community-acquired pneumonia (CAP). The aetiologic type of" exact="pneumonia" post="varied by age group (Table 1). Younger patients had"/>
  <result pre="group (Table 1). Younger patients had the highest incidence of" exact="bacterial pneumonia," post="predominantly due to higher incidence of M pneumoniae and"/>
  <result pre="likely to have a pathogen identified. The different types of" exact="pneumonia" post="were not associated with disease severity. Empirical Antibiotic Treatment"/>
  <result pre="piperacillin-tazobactam monotherapy without macrolide. Among the 20 patients with nonsevere" exact="pneumonia" post="given nonadherent antibiotics, 7 received piperacillin-tazobactam or meropenem, 8"/>
  <result pre="a macrolide, 2 received fluoroquinolone in the absence of documented" exact="allergy" post="to beta-lactam antibiotics, and 3 were not prescribed any"/>
  <result pre="to local treatment guidelines. DISCUSSION In this prospective cohort study," exact="viral pneumonia" post="was the most common cause of CAP. The most"/>
  <result pre="local treatment guidelines. DISCUSSION In this prospective cohort study, viral" exact="pneumonia" post="was the most common cause of CAP. The most"/>
  <result pre="performed on upper respiratory tract samples [14]. In our cohort," exact="influenza" post="and rhinovirus are the predominant viral pathogens, similar to"/>
  <result pre="In our study and others, up to &amp;gt;20% patients with" exact="viral pneumonia" post="had a bacterial copathogen [4]. This increases the difficulty"/>
  <result pre="our study and others, up to &amp;gt;20% patients with viral" exact="pneumonia" post="had a bacterial copathogen [4]. This increases the difficulty"/>
  <result pre="identifying patients not requiring antibacterial coverage in patients with confirmed" exact="viral pneumonia." post="Adopting more sensitive diagnostic tools for detection of bacterial"/>
  <result pre="[4, 15]. Younger age groups had a higher proportion of" exact="bacterial pneumonia," post="largely due to higher detection rates of M pneumoniae"/>
  <result pre="(inadequate coverage for potential drug-resistant pathogens in patients with severe" exact="pneumonia" post="or underlying bronchiectasis). In patients at low risk of"/>
  <result pre="the other hand, undertreatment was observed in patients with severe" exact="pneumonia" post="or bronchiectasis who were prescribed beta-lactam antibiotics in the"/>
  <result pre="hand, undertreatment was observed in patients with severe pneumonia or" exact="bronchiectasis" post="who were prescribed beta-lactam antibiotics in the absence of"/>
  <result pre="worse outcomes. Multiple studies have shown better outcomes in moderate-to-severe" exact="pneumonia" post="with the combination of beta-lactam and macrolide, compared with"/>
  <result pre="macrolide or fluoroquinolone resistance in S pneumoniae [23, 24] or" exact="tuberculosis" post="are prevalent [25]. Our results and others supported that"/>
  <result pre="in atypical pathogens. However, the role of doxycycline in severe" exact="pneumonia" post="is uncertain and needs further evaluation. There are some"/>
  <result pre="45% of patients hospitalized with CAP in Hong Kong. Viral" exact="pneumonia" post="was most common. Influenza virus, S pneumoniae, and M"/>
  <result pre="Disease Study 2017. Lancet2018; 392:1736–88.30496103 2.JainS, SelfWH, WunderinkRG, et al.Community-acquired" exact="pneumonia" post="requiring hospitalization among U.S. adults. N Engl J Med2015;"/>
  <result pre="U.S. adults. N Engl J Med2015; 373:415–27.26172429 3.SongJH, HuhK, ChungDRCommunity-acquired" exact="pneumonia" post="in the Asia-Pacific region. Semin Respir Crit Care Med2016;"/>
  <result pre="4.WunderinkRG, WatererGAdvances in the causes and management of community acquired" exact="pneumonia" post="in adults. BMJ2017; 358:j2471.28694251 5.HoPL, WuTC, ChaoDVK, et al.Reducing"/>
  <result pre="2020. 6.LimWS, van der EerdenMM, LaingR, et al.Defining community acquired" exact="pneumonia" post="severity on presentation to hospital: an international derivation and"/>
  <result pre="Infect Dis2014; 59:62–70.24729498 15.TorresA, LeeN, CillonizC, et al.Laboratory diagnosis of" exact="pneumonia" post="in the molecular age. Eur Respir J2016; 48:1764–78.27811073 16.HoPL,"/>
  <result pre="LaJoieAS, BrockGN, et al.Improving outcomes in elderly patients with community-acquired" exact="pneumonia" post="by adhering to national guidelines: community-acquired pneumonia organization international"/>
  <result pre="patients with community-acquired pneumonia by adhering to national guidelines: community-acquired" exact="pneumonia" post="organization international cohort study results. Arch Intern Med2009; 169:1515–24.19752410"/>
  <result pre="VallèsX, et al.Adherence to guidelines’ empirical antibiotic recommendations and community-acquired" exact="pneumonia" post="outcome. Eur Respir J2008; 32:892–901.18550608 20.MenéndezR, ReyesS, MartínezR, et"/>
  <result pre="Infect2012; 18:E71–3.22284533 23.CharlesPG, WhitbyM, FullerAJ, et al.The etiology of community-acquired" exact="pneumonia" post="in Australia: why penicillin plus doxycycline or a macrolide"/>
  <result pre="WongRY, LiF, et al.High mortality in adults hospitalized for active" exact="tuberculosis" post="in a low HIV prevalence setting. PLoS One2014; 9:e92077.24642794"/>
 </snippets>
</snippetsTree>
